Table 3 Prevalence and odds-ratios (OR) with 95% confidence intervals of previously known type 2 diabetes (T2D), screen-detected type 2 diabetes (ST2D), total type 2 diabetes (TT2D), impaired glucose tolerance (IGT), impaired fasting glucose (IFG), abnormal glucose tolerance (AGT = TT2D, IGT or IFG) of the study sample according to BMI category and gender.

355

684

325

494

550

417

2.8

5.8

18.2

< 0.001

1.8

4.0

8.9

< 0.001

1.0 (ref)

2.05

(1.01–4.17)

7.59

(3.79–15.20)

1.0 (ref)

2.04

(0.92–4.49)

4.63

(2.20–9.77)

7.0

6.4

17.5

< 0.001

2.6

8.2

12.5

< 0.001

1.0 (ref)

0.90

(0.54–1.50)

2.81

(1.70–4.65)

1.0 (ref)

2.92

(1.55–5.51)

4.60

(2.45–8.62)

9.9

12.3

35.7

< 0.001

4.5

12.2

21.3

< 0.001

1.0 (ref)

1.25

(0.82–1.91)

5.27

(3.43–8.07)

1.0 (ref)

2.67

(1.61–4.41)

5.16

(3.15–8.45)

10.4

17.1

19.7

0.004

10.1

16.9

24.5

< 0.001

1.0 (ref)

1.78

(1.19–2.65)

2.06

(1.32–3.22)

1.0 (ref)

1.63

(1.12–2.38)

2.58

(1.77–3.75)

5.9

9.2

13.5

0.002

2.0

4.5

8.6

< 0.001

1.0 (ref)

1.65

(0.99–2.76)

2.63

(1.52–4.54)

1.0 (ref)

2.38

(1.13–5.02)

4.79

(2.33–9.83)

26.2

38.6

68.9

< 0.001

16.6

33.6

54.4

< 0.001

1.0 (ref)

1.80

(1.34–2.42)

6.94

(4.88–9.85)

1.0 (ref)

2.34

(1.72–3.17)

5.69

(4.15–7.80)